
Antiverse
Antiverse develops AI-designed antibodies for challenging drug targets.
- Industry
- Biotech
- Founded
- 2017
- Team size
- 10-49 people
- Based in
- Wales, United Kingdom
Verified revenue: not connected yet
Is Antiverse yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.
About
Antiverse is a techbio company specializing in the design of antibodies for difficult drug targets such as GPCRs and ion channels. Using advanced machine learning and cell line engineering, the company develops new antibody therapeutics aimed at enabling innovative treatments for patients. Headquartered in Cardiff, Wales, United Kingdom, with an office in Boston, Massachusetts, Antiverse combines biotechnology and AI to accelerate the discovery of next-generation therapies and bring life-changing medicines to patients.
Team
- Murat Tunaboylu, CEO & Co-founder (Founder)
- Ben Holland, Co-Founder & CTO (Founder)
Audience
Followers on social networks
- YouTube @antiversehq: ≈55 subscribers (Public count, read by emrr from YouTube (rounded), 20 November 2026)
- X @antiversehq
- LinkedIn antiverse
Profile data from Stanbase.